诺瓦瓦克斯医药（Novavax，股票代码：NVAX）今日盘前大跌11.57%，引发市场广泛关注。此次大跌主要源于美国食品和药物管理局（FDA）最高疫苗官员彼得·马克斯（Peter Marks）可能离职的消息。
据《华尔街日报》等媒体报道，FDA疫苗部门负责人彼得·马克斯被迫选择辞职或被解雇，其辞职将于4月5日生效。马克斯在特朗普第一任期内对开发COVID-19疫苗发挥了关键作用，其突然离职引发了市场对疫苗政策可能发生变化的担忧。
值得注意的是，自特朗普连任总统并任命著名疫苗怀疑论者小罗伯特·肯尼迪（Robert F. Kennedy Jr）领导美国卫生与公众服务部以来，疫苗制造商股票一直承受压力。除诺瓦瓦克斯外，其他疫苗制造商股价也出现不同程度下跌，如Moderna跌13.7%，BioNTech跌5.5%，辉瑞跌1.6%。这一系列事件可能对疫苗行业的未来发展方向产生深远影响，投资者对此表示担忧。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.